Advances in Research on the Mechanism of Association Between Amino Acid Metabolism and Diabetes & Its Complications

Jin Li; Juan Chen

doi:10.54097/hgpmad62

Authors

Jin Li
Juan Chen

DOI:

https://doi.org/10.54097/hgpmad62

Keywords:

Diabetes, Amino acid metabolism, Diabetes complications, Amino acids, Insulin.

Abstract

Diabetes is a multifaceted metabolic and endocrine disease marked by abnormalities not only in glucose processing but also in lipid and amino acid metabolism. Amino acids are key contributors to the development and progression of diabetes. Beyond their role as essential components of proteins, they are actively involved in modulating insulin sensitivity and maintaining glucose balance. Growing research indicates that increased concentrations of specific amino acids are linked to greater insulin resistance and a higher likelihood of developing diabetes, while decreased levels of other amino acids may be associated with better metabolic health.

Downloads

Download data is not yet available.

References

[1] Harreiter, J. and M. Roden, [Diabetes mellitus: definition, classification, diagnosis, screening and prevention (Update 2023)]. Wien Klin Wochenschr, 2023. 135 (Suppl 1): p. 7 - 17.

[2] Fralick, M., et al., Global accessibility of therapeutics for diabetes mellitus. Nat Rev Endocrinol, 2022. 18 (4): p. 199 - 204.

[3] Vanweert, F., P. Schrauwen, and E. Phielix, Role of branched-chain amino acid metabolism in the pathogenesis of obesity and type 2 diabetes-related metabolic disturbances BCAA metabolism in type 2 diabetes. Nutr Diabetes, 2022. 12 (1): p. 35.

[4] De Bandt, J.P., X. Coumoul, and R. Barouki, Branched-Chain Amino Acids and Insulin Resistance, from Protein Supply to Diet-Induced Obesity. Nutrients, 2022. 15 (1).

[5] Saltiel, A.R., Insulin signaling in health and disease. J Clin Invest, 2021. 131 (1).

[6] Kamel, R.M., et al., Sustainable and efficient monitoring of tryptophan and tyrosine serum levels: a green HPTLC method as a biomarker for type 2 diabetes. BMC Chem, 2024. 18 (1): p. 217.

[7] Luo, Z., et al., Homocysteine concentration in coronary artery disease and severity of coronary lesions. J Cell Mol Med, 2024. 28 (12): p. e18474.

[8] Xu, T., et al., The impact of homocysteine on the risk of coronary artery diseases in individuals with diabetes: a Mendelian randomization study. Acta Diabetol, 2021. 58 (3): p. 301 - 307.

[9] Giuffrida, F.M.A., et al., Low-frequency variants in genes involved in glutamic acid metabolism and γ-glutamyl cycle and risk of coronary artery disease in type 2 diabetes. Cardiovasc Diabetol, 2024. 23 (1): p. 406.

[10] Debnath, S., et al., Tryptophan metabolites and anemia in patients with diabetic kidney disease. J Nephrol, 2023. 36 (4): p. 1083 - 1085.

[11] Wang, H., et al., Emerging Role of Ferroptosis in Diabetic Kidney Disease: Molecular Mechanisms and Therapeutic Opportunities. Int J Biol Sci, 2023. 19 (9): p. 2678 - 2694.

[12] Tian, Y., et al., Dapagliflozin improves diabetic kidney disease by inhibiting ferroptosis through β-hydroxybutyrate production. Ren Fail, 2025. 47 (1): p. 2438857.

[13] Kim, S., et al., Characterization of ferroptosis in kidney tubular cell death under diabetic conditions. Cell Death Dis, 2021. 12 (2): p. 160.

[14] Strand, N., et al., Diabetic Neuropathy: Pathophysiology Review. Curr Pain Headache Rep, 2024. 28 (6): p. 481 - 487.

[15] Guieu, R., J. Ruf, and G. Mottola, Hyperhomocysteinemia and cardiovascular diseases. Ann Biol Clin (Paris), 2022. 80 (1): p. 7 - 14.

[16] Bloomgarden, Z., Diabetes and branched-chain amino acids: What is the link? J Diabetes, 2018. 10 (5): p. 350 - 352.

[17] Garlick, P.J. and I. Grant, Amino acid infusion increases the sensitivity of muscle protein synthesis in vivo to insulin. Effect of branched-chain amino acids. Biochem J, 1988. 254 (2): p. 579 - 84.